FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912297647> ?p ?o ?g. }

• W2912297647 endingPage "48" @default.
• W2912297647 startingPage "39" @default.
• W2912297647 abstract "In this review we analyze literature data concerning participation of synovial inflammation, subchondral bone, humoral and cellular immune responses towards various cartilage autoantigens in the initiation and progression of primary osteoarthritis (OA). The vast majority of studies showed that the synovial inaflammation in OA is less pronounced than in RA but is more pronounced than in healthy people. In OA synovial tissue, macrophages and T-cells predominate in the inflammatory infiltrate. Some authors detected mast cells in the OA synovium in quantities higher than in healthy control and significantly higher than in RA patients. Most of researchers found many cytokines related to innate and adaptive immune cells in the OA synovial tissue, while in some studies the cells producing those cytokines were not identified. Among the cytokines there were both pro-inflammatory and anti-inflammatory ones: IL-1b, TNFα, IFNγ, IL-4, IL-2, IL-6, IL-8, IL-10, IL-17, IL-18. In addition, some authors detected IL-5, IL-13, IL-19, IL-21, IL-26, IL-32, and TGFb. A role of adaptive immune response in OA is supported by the presence of autoantibodies against antigen determinants of collagens type II, IX, XI, aggrecan, fibronectin fragments, in the synovial tissue, synovium fluid, and peripheral blood serum. The research data clearly support a role of chronic inflammation and changes in innate and adaptive immune response in the pathogenesis of OA thus justifying the change of the disease name from “osteoarthrosis” to “osteoarthritis”. This novel understanding of OA pathogenesis is paramount as it provides a rationale for modern anti-inflammatory treatments and discovery of new therapeutic targets. We discuss the results of studies evaluating efficacy and safety of some types of anti-inflammatory treatment of OA. Until now, treatment of OA directed on inflammation control was not successful. Thus, clinical trials of anti-TNFα anti-IL-1b strategies for the treatment of OA did not show clinically significant improvement in spite of multiple studies demonstrating elevated concentrations of TNFα and IL-1bin synovial fluid and subchondral bone in OA thus suggesting the role of these cytokines in the OA pathogenesis. On the other side, treatment with IL-1 inhibitor diacerein was found to be effective which can be explained by pleiotropic effects of this drug. It should be stressed out that in order to increase the efficacy of anti-inflammatory treatments of OA they should be initiated at early disease stages, thus necessitating the use of new informative biormarkers of early OA." @default.
• W2912297647 created "2019-02-21" @default.
• W2912297647 creator A5012932381 @default.
• W2912297647 creator A5062763212 @default.
• W2912297647 creator A5073978239 @default.
• W2912297647 date "2019-01-24" @default.
• W2912297647 modified "2023-09-25" @default.
• W2912297647 title "INFLAMMATION AND IMMUNITY: A ROLE OF PATHOGENESIS OF OSTEOARTHRITIS" @default.
• W2912297647 cites W1796140119 @default.
• W2912297647 cites W1967857969 @default.
• W2912297647 cites W1967918002 @default.
• W2912297647 cites W1988791506 @default.
• W2912297647 cites W1991227366 @default.
• W2912297647 cites W1991746648 @default.
• W2912297647 cites W1994972079 @default.
• W2912297647 cites W2011509273 @default.
• W2912297647 cites W2013352191 @default.
• W2912297647 cites W2017348165 @default.
• W2912297647 cites W2017869529 @default.
• W2912297647 cites W2026123588 @default.
• W2912297647 cites W2026172623 @default.
• W2912297647 cites W2027831505 @default.
• W2912297647 cites W2029351075 @default.
• W2912297647 cites W2036943040 @default.
• W2912297647 cites W2038773696 @default.
• W2912297647 cites W2046712927 @default.
• W2912297647 cites W2047334057 @default.
• W2912297647 cites W2047703526 @default.
• W2912297647 cites W2055019305 @default.
• W2912297647 cites W2063658309 @default.
• W2912297647 cites W2063728474 @default.
• W2912297647 cites W2063995828 @default.
• W2912297647 cites W2074830311 @default.
• W2912297647 cites W2082954333 @default.
• W2912297647 cites W2085788584 @default.
• W2912297647 cites W2088306158 @default.
• W2912297647 cites W2090906690 @default.
• W2912297647 cites W2104005171 @default.
• W2912297647 cites W2107894170 @default.
• W2912297647 cites W2109132899 @default.
• W2912297647 cites W2117595378 @default.
• W2912297647 cites W2118378925 @default.
• W2912297647 cites W2126864739 @default.
• W2912297647 cites W2129234907 @default.
• W2912297647 cites W2147416817 @default.
• W2912297647 cites W2163975077 @default.
• W2912297647 cites W2164993228 @default.
• W2912297647 cites W2167795966 @default.
• W2912297647 cites W2168530294 @default.
• W2912297647 cites W2184009992 @default.
• W2912297647 cites W2299367339 @default.
• W2912297647 cites W2507683743 @default.
• W2912297647 cites W2512607990 @default.
• W2912297647 cites W2529624115 @default.
• W2912297647 cites W4243439109 @default.
• W2912297647 cites W4249161236 @default.
• W2912297647 doi "https://doi.org/10.15789/1563-0625-2019-1-39-48" @default.
• W2912297647 hasPublicationYear "2019" @default.
• W2912297647 type Work @default.
• W2912297647 sameAs 2912297647 @default.
• W2912297647 citedByCount "7" @default.
• W2912297647 countsByYear W29122976472019 @default.
• W2912297647 countsByYear W29122976472020 @default.
• W2912297647 countsByYear W29122976472021 @default.
• W2912297647 countsByYear W29122976472023 @default.
• W2912297647 crossrefType "journal-article" @default.
• W2912297647 hasAuthorship W2912297647A5012932381 @default.
• W2912297647 hasAuthorship W2912297647A5062763212 @default.
• W2912297647 hasAuthorship W2912297647A5073978239 @default.
• W2912297647 hasBestOaLocation W29122976471 @default.
• W2912297647 hasConcept C136449434 @default.
• W2912297647 hasConcept C142724271 @default.
• W2912297647 hasConcept C193419808 @default.
• W2912297647 hasConcept C203014093 @default.
• W2912297647 hasConcept C204787440 @default.
• W2912297647 hasConcept C2776164576 @default.
• W2912297647 hasConcept C2776268809 @default.
• W2912297647 hasConcept C2776914184 @default.
• W2912297647 hasConcept C2780942790 @default.
• W2912297647 hasConcept C71924100 @default.
• W2912297647 hasConcept C8891405 @default.
• W2912297647 hasConceptScore W2912297647C136449434 @default.
• W2912297647 hasConceptScore W2912297647C142724271 @default.
• W2912297647 hasConceptScore W2912297647C193419808 @default.
• W2912297647 hasConceptScore W2912297647C203014093 @default.
• W2912297647 hasConceptScore W2912297647C204787440 @default.
• W2912297647 hasConceptScore W2912297647C2776164576 @default.
• W2912297647 hasConceptScore W2912297647C2776268809 @default.
• W2912297647 hasConceptScore W2912297647C2776914184 @default.
• W2912297647 hasConceptScore W2912297647C2780942790 @default.
• W2912297647 hasConceptScore W2912297647C71924100 @default.
• W2912297647 hasConceptScore W2912297647C8891405 @default.
• W2912297647 hasIssue "1" @default.
• W2912297647 hasLocation W29122976471 @default.
• W2912297647 hasOpenAccess W2912297647 @default.
• W2912297647 hasPrimaryLocation W29122976471 @default.
• W2912297647 hasRelatedWork W1556307916 @default.
• W2912297647 hasRelatedWork W1557621914 @default.

• next